Saturday, March 31, 2018

Pediatric cancer drug shows 93 percent response rate

A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers say.

from Top Health News -- ScienceDaily https://ift.tt/2GH6WQ8
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

This pet gecko could help scientists unlock the secrets of cancer

An unusual leopard gecko that naturally develops aggressive tumors may become an important new model for cancer research. Scientists found i...